WallStreetZenWallStreetZen

NASDAQ: SLP
Simulations Plus Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

SLP past earnings growth

How has SLP's earnings growth performed historically?
Company
1.92%
Industry
-4.41%
Market
72.53%
SLP's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
SLP's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
SLP's earnings growth is slowing... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

SLP past revenue growth

How has SLP's revenue growth performed historically?
Company
18.86%
Industry
11.9%
Market
17.76%
SLP's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
SLP's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
SLP's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

SLP earnings and revenue history

Current Revenue
$64.7M
Current Earnings
$10.5M
Current Profit Margin
16.3%
SLP's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

SLP Return on Equity

Insufficient data to display
SLP's Return on Equity (6.1%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when SLP announces earnings.

SLP Return on Assets

Insufficient data to display
SLP is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

SLP Return on Capital Employed

Insufficient data to display
SLP's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

SLP vs Health Information Service Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
SLP$64.67M$16.85M$10.52M+15.66%+4.27%
NRC$148.58M$46.72M$30.97M+4.42%+3.13%
HSTM$282.88M$63.40M$17.82M+3.18%+5.68%
DH$251.42M-$153.99M-$202.39M+104.00%N/A
ACCD$414.29M-$59.36M-$99.81M+34.30%N/A
View Top Health Information Service Stocks

Simulations Plus Earnings & Revenue FAQ

What were SLP's earnings last quarter?

On Invalid Date, Simulations Plus (NASDAQ: SLP) reported Q1 2024 earnings per share (EPS) of $0.20, up 4.76% year over year. Total Simulations Plus earnings for the quarter were $4.03 million. In the same quarter last year, Simulations Plus's earnings per share (EPS) was $0.21.

If you're new to stock investing, here's how to buy Simulations Plus stock.

What was SLP's earnings growth in the past year?

As of Q2 2024, Simulations Plus's earnings has grown 1.92% year over year. This is 6.33 percentage points higher than the US Health Information Services industry earnings growth rate of -4.41%. Simulations Plus's earnings in the past year totalled $10.52 million.

What was SLP's revenue last quarter?

On Invalid Date, Simulations Plus (NASDAQ: SLP) reported Q1 2024 revenue of $18.31 million up 16.22% year over year. In the same quarter last year, Simulations Plus's revenue was $15.75 million.

What was SLP's revenue growth in the past year?

As of Q2 2024, Simulations Plus's revenue has grown 18.86% year over year. This is 6.96 percentage points higher than the US Health Information Services industry revenue growth rate of 11.9%. Simulations Plus's revenue in the past year totalled $64.67 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.